CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,775,997 | +4167.7% | 551,914 | +6423.0% | 0.01% | – |
| Q2 2023 | $88,478 | +89.0% | 8,461 | +26.0% | 0.00% | – |
| Q1 2023 | $46,811 | +15.6% | 6,716 | 0.0% | 0.00% | – |
| Q4 2022 | $40,497 | -23.6% | 6,716 | 0.0% | 0.00% | – |
| Q3 2022 | $53,000 | -96.5% | 6,716 | -94.0% | 0.00% | -100.0% |
| Q2 2022 | $1,517,000 | -30.5% | 111,435 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,184,000 | -57.3% | 111,435 | -21.3% | 0.00% | -57.1% |
| Q4 2021 | $5,115,000 | -77.3% | 141,602 | -65.6% | 0.01% | -80.6% |
| Q3 2021 | $22,487,000 | -57.5% | 411,444 | -42.8% | 0.04% | -58.1% |
| Q2 2021 | $52,919,000 | +55.5% | 719,540 | +93.4% | 0.09% | +36.5% |
| Q1 2021 | $34,036,000 | – | 372,141 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $286,707,000 | 46.92% |
| Ally Bridge Group (NY) LLC | 110,000 | $10,061,000 | 1.93% |
| Parametrica Management Ltd | 44,695 | $3,968,000 | 1.91% |
| Renaissance Capital LLC | 123,983 | $11,339,000 | 1.68% |
| Samsara BioCapital, LLC | 95,318 | $8,718,000 | 1.61% |
| Ikarian Capital, LLC | 360,000 | $32,925,000 | 1.11% |
| SECTOR GAMMA AS | 25,000 | $2,287,000 | 0.42% |
| Fosun International Ltd | 50,000 | $4,438,000 | 0.35% |
| Ikarian Capital, LLC | 100,000 | $9,145,000 | 0.31% |
| Baillie Gifford | 5,830,101 | $533,221,000 | 0.30% |